|
Volume 270,
Number 15,
Issue of April 14, pp. 8650-8654, 1995
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Different
Susceptibility of Small and Large Human Tenascin-C Isoforms to
Degradation by Matrix Metalloproteinases
Annalisa
Siri
,
Vera
Knäuper
,
Natalia
Veirana
,
Fabio
Caocci
,
Gillian
Murphy
,
Luciano
Zardi
Two major tenascin-C (TN-C) isoforms are generated by the
alternative splicing of the pre-mRNA. The large isoform contains seven
extra type three repeats that, by contrast, are omitted in the small
TN-C isoform. The large TN-C isoform is mainly expressed at the onset
of cellular processes that entail active cell migration, proliferation,
or tissue remodeling such as occur in neoplasia, wound healing, and
during development. Thus, the large TN-C isoform seems to be a specific
component of the provisional extracellular matrix. Here we have studied
the degradation of the large and small TN-C isoforms by matrix
metalloproteinases (MMPs) 2, 3, 7, and 9. Among these proteolytic
enzymes only MMP-7 can degrade the small TN-C isoform removing the
NH -terminal knob. The large TN-C isoform shows the same
MMP-7-sensitive site adjacent to the NH -terminal sequence,
but is further degraded in the splicing area where three
fibronectin-like type III repeats are completely digested. Moreover,
the large TN-C isoform is degraded by MMP-2 and MMP-3 which completely
digest a single type III repeat inside the splicing area. By contrast,
the large TN-C isoform is resistant to MMP-9 digestion. The results
show that the presence of the spliced sequence introduces new
protease-sensitive sites in the large TN-C isoform.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Saito, H. Imazeki, S. Miura, T. Yoshimura, H. Okutsu, Y. Harada, T. Ohwaki, O. Nagao, S. Kamiya, R. Hayashi, et al.
A Peptide Derived from Tenascin-C Induces 1 Integrin Activation through Syndecan-4
J. Biol. Chem.,
November 30, 2007;
282(48):
34929 - 34937.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kabosova, D. T. Azar, G. A. Bannikov, K. P. Campbell, M. Durbeej, R. F. Ghohestani, J. C. R. Jones, M. C. Kenney, M. Koch, Y. Ninomiya, et al.
Compositional Differences between Infant and Adult Human Corneal Basement Membranes
Invest. Ophthalmol. Vis. Sci.,
November 1, 2007;
48(11):
4989 - 4999.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Bouvet, L.-A. Gilbert, D. Girardot, D. deBlois, and P. Moreau
Different Involvement of Extracellular Matrix Components in Small and Large Arteries During Chronic NO Synthase Inhibition
Hypertension,
March 1, 2005;
45(3):
432 - 437.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Wallner, C. Li, P. K. Shah, K.-J. Wu, S. M. Schwartz, and B. G. Sharifi
EGF-Like Domain of Tenascin-C Is Proapoptotic for Cultured Smooth Muscle Cells
Arterioscler. Thromb. Vasc. Biol.,
August 1, 2004;
24(8):
1416 - 1421.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Tsunoda, H. Inada, I. Kalembeyi, K. Imanaka-Yoshida, M. Sakakibara, R. Okada, K. Katsuta, T. Sakakura, Y. Majima, and T. Yoshida
Involvement of Large Tenascin-C Splice Variants in Breast Cancer Progression
Am. J. Pathol.,
June 1, 2003;
162(6):
1857 - 1867.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Adams, J. L. Jones, R. A. Walker, J. H. Pringle, and S. C. Bell
Changes in Tenascin-C Isoform Expression in Invasive and Preinvasive Breast Disease
Cancer Res.,
June 1, 2002;
62(11):
3289 - 3297.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Cai, K. Onoda, M. Takao, I.-Y. Kyoko, H. Shimpo, T. Yoshida, and I. Yada
Degradation of Tenascin-C and Activity of Matrix Metalloproteinase-2 Are Associated with Tumor Recurrence in Early Stage Non-Small Cell Lung Cancer
Clin. Cancer Res.,
April 1, 2002;
8(4):
1152 - 1156.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Steffensen, L. Hakkinen, and H. Larjava
Proteolytic Events of Wound-Healing -- Coordinated Interactions Among Matrix Metalloproteinases (MMPs), Integrins, and Extracellular Matrix Molecules
Critical Reviews in Oral Biology & Medicine,
January 1, 2001;
12(5):
373 - 398.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. O. Stracke, M. Hutton, M. Stewart, A. M. Pendas, B. Smith, C. Lopez-Otin, G. Murphy, and V. Knauper
Biochemical Characterization of the Catalytic Domain of Human Matrix Metalloproteinase 19. EVIDENCE FOR A ROLE AS A POTENT BASEMENT MEMBRANE DEGRADING ENZYME
J. Biol. Chem.,
May 12, 2000;
275(20):
14809 - 14816.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.C. Bell, J.H. Pringle, D.J. Taylor, and T.M. Malak
Alternatively spliced tenascin-C mRNA isoforms in human fetal membranes
Mol. Hum. Reprod.,
November 1, 1999;
5(11):
1066 - 1076.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Wilson, A. J. Ouellette, D. P. Satchell, T. Ayabe, Y. S. López-Boado, J. L. Stratman, S. J. Hultgren, L. M. Matrisian, and W. C. Parks
Regulation of Intestinal -Defensin Activation by the Metalloproteinase Matrilysin in Innate Host Defense
Science,
October 1, 1999;
286(5437):
113 - 117.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Potter-Perigo, E. D. Kaplan, D. L. Luchtel, C. Baker, L. C. Altman, and T. N. Wight
Ozone Alters the Expression of Tenascin-C in Cultured Primate Nasal Epithelial Cells
Am. J. Respir. Cell Mol. Biol.,
April 1, 1998;
18(4):
471 - 478.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. A. Rudolph-Owen, P. Cannon, and L. M. Matrisian
Overexpression of the Matrix Metalloproteinase Matrilysin Results in Premature Mammary Gland Differentiation and Male Infertility
Mol. Biol. Cell,
February 1, 1998;
9(2):
421 - 435.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. Phillips, L. Krushel, and K. Crossin
Domains of tenascin involved in glioma migration
J. Cell Sci.,
January 4, 1998;
111(8):
1095 - 1104.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Knauper, S. Cowell, B. Smith, C. Lopez-Otin, M. O'Shea, H. Morris, L. Zardi, and G. Murphy
The Role of the C-terminal Domain of Human Collagenase-3 (MMP-13) in the Activation of Procollagenase-3, Substrate Specificity, and Tissue Inhibitor of Metalloproteinase Interaction
J. Biol. Chem.,
March 21, 1997;
272(12):
7608 - 7616.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Deryugina, M. Bourdon, G. Luo, R. Reisfeld, and A Strongin
Matrix metalloproteinase-2 activation modulates glioma cell migration
J. Cell Sci.,
January 10, 1997;
110(19):
2473 - 2482.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Benbow, G. Butticè, H. Nagase, and M. Kurkinen
Characterization of the 46-kDa Intermediates of Matrix Metalloproteinase 3 (Stromelysin 1) Obtained by Site-directed Mutation of Phenylalanine 83
J. Biol. Chem.,
May 3, 1996;
271(18):
10715 - 10722.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1995 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|